MindMaze Therapeutics Holding SA
Close on Oct 19, 2026
About MindMaze Therapeutics
Pharmaceutical Preparations, SIC 2834
RELIEF THERAPEUTICS Holding SA is a biopharmaceutical enterprise engaged in developing, licensing, and commercializing therapeutic treatments and pharmaceutical assets. The organization offers on-market and pipeline products across several clinical initiatives, including PKU GOLIKER, Sentinox, diclofenac, and the ACER-001 asset. Operating primarily through licensing agreements, product sales, and research and development arrangements, the company provides therapies across specialized disease areas to partner organizations, distributors, and global biopharma collaborators.
The company operates internationally across Switzerland, North America, and other European markets through several operational affiliates, including APR Applied Pharma Research and AdVita Lifescience entities. The group carries out its corporate administrative affairs, strategic business management, and principal operations from its corporate headquarters based in Geneva, Switzerland.
Summary of the business section of MindMaze Therapeutics's latest annual report, written by StockData.
Company profile
Company
- Legal name
- MindMaze Therapeutics Holding SA
- Headquarters
- Ch-1202 Geneva, Switzerland
- Address
- Avenue De Secheron 15
- Phone
- (914) 672-3555
- Employees
- 49, Dec 31, 2023
- Industry
- Pharmaceutical Preparations
- Incorporated in
- V8
- Fiscal year ends
- December 31
- Auditor
- MAZARS SA, Switzerland, Geneva
Stock & identifiers
- Ticker
- MMTZF
- Other tickers
- RLFTY
- Exchange
- OTC
- Shares outstanding
- 13M, Dec 31, 2023
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-400 reverse, Apr 30, 2024; 1-for-400 reverse, May 5, 2023
- SEC CIK
- 1854078
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
MindMaze Therapeutics's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 27, 2025 | Name change | Name changed from Relief Therapeutics Holding SA to MindMaze Therapeutics Holding SA |
| Dec 17, 2024 | Deregistration | Termination of SEC registration (Form 15) |
| May 2, 2023 | Late filing | Notification of late filing |
| Mar 30, 2021 | Name change | Name changed from Relief Therapeutics Holding AG to Relief Therapeutics Holding SA |